ENCOMPASS HEALTH CORP (EHC) Forecast, Price Target & Analyst Ratings

NYSE:EHCUS29261A1007

Current stock price

97.49 USD
-0.03 (-0.03%)
At close:
97.49 USD
0 (0%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ENCOMPASS HEALTH CORP (EHC).

Forecast Snapshot

Consensus Price Target

Price Target
$144.08
+ 47.78% Upside

Next Earnings Forecast

Earnings Estimate
Release Date
Apr 22, 2026
Period
Q1 / 2026
EPS Estimate
$1.52
Revenue Estimate
1.592B

ChartMill Buy Consensus

Rating
87.50%
Weighted Analyst Rating Score

Price Target Details & History

Consensus Price Target and Range

Mean target
$144.08
Upside
+ 47.78%
From current price of $97.49 to mean target of $144.08, Based on 16 analyst forecasts
Low
$126.25
Median
$142.80
High
$168.00

Price Target Revisions

1 Month
0.65%
3 Months
0.65%

Price Target Summary

16 Wall Street analysts provided a forecast for the next 12 months for EHC. The average price target is 144.07 USD. This implies a price increase of 47.78% is expected in the next year compared to the current price of 97.49.
The average price target has been revised upward by 0.65% in the past 3 months.

Analyst Ratings & History

Current Analyst Ratings

EHC Current Analyst RatingEHC Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6

Analyst Ratings History

EHC Historical Analyst RatingsEHC Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15

Analyst Ratings Consensus

ChartMill Buy Consensus
87.50%
EHC was analyzed by 16 analysts. The buy percentage consensus is at 88. So analysts seem to be very confident about EHC.
In the previous month the buy percentage consensus was at a similar level.
EHC was analyzed by 16 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-02-06BarclaysMaintains Overweight -> Overweight
2025-10-30BarclaysMaintains Overweight -> Overweight
2025-10-02UBSMaintains Buy -> Buy
2025-09-16KeybancMaintains Overweight -> Overweight
2025-09-10B of A SecuritiesMaintains Buy -> Buy
2025-08-14Truist SecuritiesMaintains Buy -> Buy
2025-08-06UBSMaintains Buy -> Buy
2025-06-05Stephens & Co.Reiterate Overweight -> Overweight
2025-05-27KeybancMaintains Overweight -> Overweight
2025-04-28UBSMaintains Buy -> Buy
2025-04-28RBC CapitalMaintains Outperform -> Outperform
2025-04-28Truist SecuritiesReiterate Buy -> Buy
2025-04-25KeybancMaintains Overweight -> Overweight
2025-04-25BarclaysMaintains Overweight -> Overweight
2025-02-11RBC CapitalReiterate Outperform -> Outperform
2025-02-10KeybancMaintains Overweight -> Overweight
2025-02-07BarclaysMaintains Overweight -> Overweight
2024-10-30RBC CapitalMaintains Outperform -> Outperform
2024-10-30Truist SecuritiesReiterate Buy -> Buy
2024-10-29KeybancMaintains Overweight -> Overweight
2024-10-29BarclaysMaintains Overweight -> Overweight
2024-10-14Truist SecuritiesMaintains Buy -> Buy
2024-10-11KeybancInitiate Overweight
2024-09-26RBC CapitalMaintains Outperform -> Outperform
2024-09-25UBSMaintains Buy -> Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
Apr 22, 2026
Period
Q1 / 2026
EPS Estimate
$1.52
Revenue Estimate
1.592B
Revenue Q2Q
9.39%
EPS Q2Q
10.84%
Number of Analysts
13

Next Earnings Revisions

Revenue (1 Month)
-0.06%
Revenue (3 Months)
-0.50%
EPS (1 Month)
-0.11%
EPS (3 Months)
0.21%

Next Earnings Summary

EHC is expected to report earnings on 4/22/2026. The consensus EPS estimate for the next earnings is 1.52 USD and the consensus revenue estimate is 1.59B USD.
The next earnings revenue estimate has been revised downward by 0.5% in the past 3 months.

Full Analyst Estimates 2026 - 2029

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029
Revenue
YoY % growth
EHC revenue by date.EHC revenue by date.
4.801B
10.41%
5.373B
11.91%
5.935B
10.46%
6.492B
9.38%
7.02B
8.13%
7.565B
7.76%
8.019B
6.00%
EBITDA
YoY % growth
EHC ebitda by date.EHC ebitda by date.
1.006B
15.09%
1.164B
15.75%
1.381B
18.63%
1.389B
0.58%
1.503B
8.21%
1.656B
10.18%
N/A
EBIT
YoY % growth
EHC ebit by date.EHC ebit by date.
731.8M
16.12%
864.5M
18.13%
1.053B
21.82%
1.069B
1.51%
1.163B
8.79%
1.259B
8.25%
N/A
Operating Margin
EHC operating margin by date.EHC operating margin by date.
15.24%16.09%17.74%16.47%16.57%16.64%N/A
EPS
YoY % growth
EHC eps by date.EHC eps by date.
3.64
6.74%
4.43
21.70%
5.46
23.25%
6.02
10.23%
6.54
8.66%
7.24
10.75%
7.77
7.24%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth
1.52
10.84%
1.50
7.22%
1.38
12.36%
1.45
-0.68%
1.60
5.34%
1.58
5.08%
1.46
5.51%
1.49
2.82%
Revenue
Q2Q % growth
1.592B
9.39%
1.594B
9.35%
1.619B
9.58%
1.688B
9.28%
1.737B
9.11%
1.738B
9.03%
1.757B
8.52%
1.823B
8.00%
EBITDA
Q2Q % growth
346.48M
0.08%
345.46M
-17.39%
332.13M
-31.53%
342.71M
-43.94%
369.58M
6.67%
369.04M
6.83%
360.17M
8.44%
365.7M
6.71%
EBIT
Q2Q % growth
269.38M
0.89%
267.14M
3.10%
251.64M
3.30%
256.1M
-9.63%
N/AN/AN/AN/A

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

EHC Yearly Revenue VS EstimatesEHC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2B 4B 6B 8B
EHC Yearly EPS VS EstimatesEHC Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
9.87%
EPS Next 5 Year
9.21%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
8.07%
Revenue Next 5 Year
7.55%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
19.43%
EBIT Next 5 Year
N/A

ENCOMPASS HEALTH CORP / EHC Forecast FAQ

What is the price target for EHC stock?

16 analysts have analysed EHC and the average price target is 144.07 USD. This implies a price increase of 47.78% is expected in the next year compared to the current price of 97.49.

What is the next earnings date for EHC stock?

ENCOMPASS HEALTH CORP (EHC) will report earnings on 2026-04-22, after the market close.

Can you provide the consensus estimates for ENCOMPASS HEALTH CORP next earnings?

The consensus EPS estimate for the next earnings of ENCOMPASS HEALTH CORP (EHC) is 1.52 USD and the consensus revenue estimate is 1.59B USD.

Can you provide the consensus rating for ENCOMPASS HEALTH CORP stock?

The consensus rating for ENCOMPASS HEALTH CORP (EHC) is 87.5 / 100 . This indicates that analysts generally have a positive outlook on the stock.